Table 3 ET-1 plasma and urine levels at 3 selected time points in HSP patients and controls
From: Endothelin 1 levels in relation to clinical presentation and outcome of Henoch Schonlein purpura
ET-1 in patients (mean ± SD)) | ET-1 in controls (mean ± SD) | p | ||
|---|---|---|---|---|
1st measurement | Plasma | 15.66 ± 4.30 | 16.75 ± 5.96 | 0.41 |
Urine | 37.44 ± 30.78 | 45.31 ± 20.33 | 0.24 | |
2nd measurement | Plasma | 16.11 ± 3.26 | 16.75 ± 5.96 | 0.60 |
Urine | 42.01 ± 18.64 | 45.31 ± 20.33 | 0.51 | |
3rd measurement | Plasma | 16.14 ± 3.60 | 16.75 ± 5.96 | 0.63 |
Urine | 46.95 ± 23.15 | 45.31 ± 20.33 | 0.77 |